These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 1888693)

  • 1. Twenty-four hour ambulatory blood pressure profile of a new slow-release formulation of diltiazem in mild to moderate hypertension.
    Dupont AG; Coupez JM; Jensen P; Coupez-Lopinot R; Schoors DF; Hermanns P; Nicolas M
    Cardiovasc Drugs Ther; 1991 Aug; 5(4):701-7. PubMed ID: 1888693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical experience with a once-daily, extended-release formulation of diltiazem in the treatment of hypertension.
    Graney WF
    Am J Med; 1992 Aug; 93(2A):56S-64S. PubMed ID: 1519637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sustained antihypertensive activity of diltiazem SR: double-blind, placebo-controlled study with 24-hour ambulatory blood pressure monitoring.
    Whelton A; Eff J; Magner DJ
    J Clin Pharmacol; 1992 Sep; 32(9):808-15. PubMed ID: 1430300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antihypertensive efficacy and safe use of once-daily sustained-release diltiazem in the elderly: a comparison with captopril. The Dilcacomp Study Group.
    Nicaise J; Neveux E; Blondin P
    J Int Med Res; 1995; 23(4):244-53. PubMed ID: 7589767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of graded-release diltiazem versus ramipril, dosed at bedtime, on early morning blood pressure, heart rate, and the rate-pressure product.
    White WB; Lacourciere Y; Gana T; Pascual MG; Smith DH; Albert KS
    Am Heart J; 2004 Oct; 148(4):628-34. PubMed ID: 15459593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trough-to-peak ratio and circadian blood pressure profile after treatment with once-daily extended-release diltiazem, 240 mg, in patients with mild-to-moderate essential hypertension.
    Coca A; Sobrino J; Soler J; Módol J; Palos MA; Mínguez A; Esqúe J; Plana J; Cases M; Closas J; de la Sierra A
    J Cardiovasc Pharmacol; 1997 Mar; 29(3):316-22. PubMed ID: 9125668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 24-hour efficacy of once-daily diltiazem in essential hypertension.
    Massie BM; Der E; Herman TS; Topolski P; Park GD; Stewart WH
    Clin Cardiol; 1992 May; 15(5):365-8. PubMed ID: 1623657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antihypertensive effect of diltiazem in a slow-release formulation for mild to moderate essential hypertension.
    Nikkilä MT; Inkovaara JA; Heikkinen JT; Olsson SO
    Am J Cardiol; 1989 May; 63(17):1227-30. PubMed ID: 2711992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ambulatory blood pressure profiles in patients treated with once-daily diltiazem extended-release or indapamide alone or in combination.
    Prisant LM;
    Am J Ther; 2000 May; 7(3):177-84. PubMed ID: 11317166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical efficacy of force titrated doses of diltiazem extended-release. A placebo controlled study.
    Lacourcière Y; Poirier L; Lefebvre J; Burford RG
    Am J Hypertens; 1995 Mar; 8(3):282-6. PubMed ID: 7794578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of sustained-release diltiazem on blood pressure and serum lipids: a multicenter, randomized, placebo-controlled study.
    Djian J; Fermé I; Zannad F; Chaignon M; Asmar R
    J Cardiovasc Pharmacol; 1990; 16 Suppl 1():S38-45. PubMed ID: 1706012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antihypertensive efficacy of twice daily controlled release diltiazem using 24 hour intra-arterial blood pressure monitoring.
    Sridhara BS; Thomas P; Lahiri A; Raftery EB
    Eur J Clin Pharmacol; 1994; 46(5):427-30. PubMed ID: 7957537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Assessment of the anti-hypertensive effect of diltiazem in delayed-action capsules by ambulatory monitoring of arterial pressure].
    Amado P; Azevedo J; Arroja I; Castanheira J; Carmona J; Araújo VP
    Rev Port Cardiol; 1992 Mar; 11(3):239-45. PubMed ID: 1610610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Once daily compared with twice daily administration of slow-release diltiazem as monotherapy for hypertension.
    Nikkilä M; Inkovaara J; Heikkinen J
    Ann Med; 1991 Apr; 23(2):141-5. PubMed ID: 2069791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative study on monotherapy with sustained-release diltiazem 300 mg and enalapril 20 mg in mild to moderate arterial hypertension.
    Fermé I; Djian J; Tcherdakoff P
    J Cardiovasc Pharmacol; 1990; 16 Suppl 1():S46-50. PubMed ID: 1706014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sustained-release diltiazem: duration of antihypertensive effect.
    Pool PE; Herron JM; Rosenblatt S; Reeves RL; Nappi JM; Staker LV; Dipette DJ; Evans RR
    J Clin Pharmacol; 1989 Jun; 29(6):533-7. PubMed ID: 2666454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 24 hour blood pressure control with once-daily versus twice-daily formulations of diltiazem.
    Ruddy TD; Wright JM; Savard D; Handa SP; Chockalingam A; Fischer L; Boulet AP
    Cardiovasc Drugs Ther; 1995 Dec; 9(6):799-807. PubMed ID: 8850385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of atenolol and diltiazem-SR on exercise and pressure load in hypertensive patients.
    Chrysant SG; Miller E
    Clin Cardiol; 1994 Dec; 17(12):670-4. PubMed ID: 7867240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Ambulatory measurement of blood pressure and efficacy of diltiazem. Influence of the timing of drug ingestion and initial blood pressure level].
    Bernard-Fernier MF; Renucci JF; Siche JP; Vaisse B; Poggi L; Mallion JM
    Ann Cardiol Angeiol (Paris); 1994 Jun; 43(6):357-64. PubMed ID: 8085776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of diltiazem retard on ambulatory blood pressure and heart rate variability in patients with essential hypertension.
    Kawano Y; Makino Y; Okuda N; Takishita S; Omae T
    Blood Press Monit; 2000 Jun; 5(3):181-5. PubMed ID: 10915232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.